International experience in drug assessment for rare diseases: flexibility of approaches
Relevance. The regulation of orphan drugs plays a key role in the development of medicines for rare diseases that affect only a small percentage of the population. This specialized regulatory framework is designed to encourage pharmaceutical companies to allocate resources to the development of drug...
Saved in:
Main Authors: | K. S. Radaeva, A. S. Kolbin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Publishing House OKI
2024-09-01
|
Series: | Реальная клиническая практика: данные и доказательства |
Subjects: | |
Online Access: | https://www.myrwd.ru/jour/article/view/67 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES
by: V. V. Omelyanovskiy, et al.
Published: (2015-05-01) -
Current issues related to the off-label use of drugs and their potential solutions
by: K. S. Radaeva, et al.
Published: (2024-04-01) -
Current Problems in Provision of Orphan Drugs and Ways to Solve Them
by: Alexei S. Kolbin, et al.
Published: (2016-09-01) -
Visual Research of Global Orphan Drug from a Bibliometric Perspective
by: Wen X, et al.
Published: (2025-05-01) -
REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS
by: Andrey Vladislavovich Pavlysh, et al.
Published: (2015-09-01)